skip to main content

The Terry Fox Research Institute (TFRI), named for Canadian icon Terry Fox, is built on Terry's dream to end cancer through research.

News & Notices

  • Save the date: The annual TFRI Ontario Node Symposium will be held Dec.4, 2017

    The annual Terry Fox Research Institute Ontario Node Symposium is just around the corner, and will be held on Dec. 4, 2017 at at the the MaRS Discovery Centre in Toronto.

    Read More View all notices

  • Canadian, international researchers find new candidate drivers, subtype diversity in study of whole-genome landscape for children’s brain cancer

    A new study has analyzed hundreds of sequenced medulloblastoma (MB) samples, identifying new targets that could give children with this disease less harmful therapeutic options.

    Read More View all notices

  • Vancouver team identifies new class of molecules with potential in treating metastatic prostate cancer

    A recent study by a prolific TFRI-funded team has demonstrated that disrupting ERG transcriptional activity is sufficient to suppress the major characteristics of ERG-transformed prostate cancers.

    Read More View all notices

  • Vaccine shows promise in models, eradicates intra-abdominal tumours in over 90 per cent of mice

    Ontario cancer researchers have found that an oncolytic virus may lead to a promising new therapy option for patients with peritoneal carcinomatosis, a disseminated intra-abdominal tumour.

    Read More View all notices

September is Childhood Cancer Awareness Month 

Is immunotherapy effective in childhood cancers? TFRI researcher aims to find out

How do different pediatric tumours respond to immunotherapy? That’s the primary question a newly funded TFRI investigator seeks to answer.

Read more  More research stories

September is Childhood Cancer Awareness Month -- here's how TFRI researchers are making a difference. 

Our Mission & Vision

Terry's vision unites us and inspires our research excellence, innovation and creativity. The Terry Fox Research Institute is a collaboratively oriented, pan-Canadian organization focused on improving cancer research outcomes for the benefit of cancer patients everywhere. We invest in and manage translational research projects across Canada and function as the research arm of The Terry Fox Foundation, managing and overseeing its discovery and training portfolios. We want to ensure that today’s best science becomes tomorrow’s affordable medicine.

Back to Top